Summary
- Current Price
- As of today, IMRX price is $4.50, down -22.10% on
- Current Price All-Time High
- IMRX price is currently -86.78% below its historical high of $33.99 set on
- Market Cap
- IMRX current market cap is $291M, up +372.60% over the past 365 days
- PE Ratio
- IMRX PE ratio is unknown
- Revenue
- IMRX current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for IMRX has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Immuneering Corporation |
| Ticker | NASDAQ: IMRX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | immuneering.com |
| Employees | 54 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $4.50 | ||
| Price, 1D Change | -22.10% | |
| $291M | ||
| - | ||
| - | ||
| 1.32 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.27 | ||
| EPS, 1Y Change | +37.47% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.27 | ||
| EPS Estimate | N/A | -$1.14 |
| EPS Est. Change | N/A | +10.71% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $4.50 | ||
| Price Target | - | $14.50 |
| Price Tgt. Change | - | +222.58% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.82 | -$2.04 | -11.70% | |
| -$1.42 | -$1.27 | +10.14% | |
| -$1.14 | N/A | +10.71% | |
| -$1.34 | N/A | -5.13% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $16.00M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +162.87% | ||
| -52.28% | ||
| +372.60% | ||
| +5.55% | ||
| 0.00% | ||
| -100.00% | ||
| +37.47% | ||
| +33.50% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $4.50 | ||
| $5.82 | ||
| $5.34 | ||
| $5.15 | ||
| $5.28 | ||
| -$0.07 | ||
| 1.32 | ||
| $0.51 | ||
| 38.97 | ||
| 147.26% | ||
| 124.18% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$1.27 | ||
| -$698.90K | ||
| - | ||
| -$59.38M | ||
| - | ||
| -$56.02M | ||
| - | ||
| -$58.68M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.02 | ||
| 17.50 | ||
| 17.50 | ||
| - | ||
| - | ||
| 11.25 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 1.41 | ||
| -2.35 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $218.48M | ||
| $172.83M | ||
| $231.99M | ||
| $176.25M | ||
| $13.50M | ||
| $10.07M | ||
| $3.82M | ||
| $397.10K | ||
| $1.54M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $56.02M | ||
| $58.68M | ||
| $698.90K | ||
| $0.00 | ||
| $698.90K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$45.34M | ||
| -$88.74M | ||
| $226.58M | ||
| $142.20K | ||
| -$45.49M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Chardan Capital | → | |
| Needham | → | |
| Chardan Capital | → | |
| Leerink Partners | ||
| HC Wainwright & Co. | → | |
| Chardan Capital | → | |
| Oppenheimer | → | |
| Needham | → | |
| Needham | → | |
| Chardan Capital | → |
Analyst sentiment
Institutional ownership
Screeners with IMRX
FAQ
What is the ticker symbol for Immuneering Corporation?
The ticker symbol for Immuneering Corporation is NASDAQ:IMRX
Does Immuneering Corporation pay dividends?
No, Immuneering Corporation does not pay dividends
What sector is Immuneering Corporation in?
Immuneering Corporation is in the Healthcare sector
What industry is Immuneering Corporation in?
Immuneering Corporation is in the Biotechnology industry
What country is Immuneering Corporation based in?
Immuneering Corporation is headquartered in United States
When did Immuneering Corporation go public?
Immuneering Corporation initial public offering (IPO) was on July 30, 2021
Is Immuneering Corporation in the S&P 500?
No, Immuneering Corporation is not included in the S&P 500 index
Is Immuneering Corporation in the NASDAQ 100?
No, Immuneering Corporation is not included in the NASDAQ 100 index
Is Immuneering Corporation in the Dow Jones?
No, Immuneering Corporation is not included in the Dow Jones index
When was Immuneering Corporation last earnings report?
Immuneering Corporation's most recent earnings report was on November 13, 2025
When does Immuneering Corporation report earnings?
The date for Immuneering Corporation's next earnings report has not been announced yet
Data Sources & References
- IMRX Official Website immuneering.com
- IMRX Profile on Yahoo Finance finance.yahoo.com/quote/IMRX
- IMRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/imrx